Alex J. Liu

Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors

Alex J. Liu, Benjamin E. Ueberroth, Patrick W. McGarrah et al. · The Oncologist · 2021 · 46 citations · Full text

Outcomes on <scp>anti‐VEGFR</scp>‐2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma

Lionel Aurelien Kankeu Fonkoua, Sakti Chakrabarti, Mohamad Bassam Sonbol et al. · International Journal of Cancer · 2021 · 25 citations · Full text

Cancer Immunosurveillance, Gastrointestinal Oncology, Medicine +13

Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options

Benjamin E. Ueberroth, Alex J. Liu, Jason S. Starr et al. · Clinical Colorectal Cancer · 2020 · 14 citations

Patient Characteristics, Neuro-oncology, Surgical Oncology +8

Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms

Jennifer Gile, Alex J. Liu, Patrick W. McGarrah et al. · Pancreas · 2021 · 14 citations

The impact of genetic aberrations on response to radium‐223 treatment for castration‐resistant prostate cancer with bone metastases

Alex J. Liu, Heidi Kosiorek, Benjamin E. Ueberroth et al. · The Prostate · 2022 · 11 citations